In 2021, Lin et al. identified SETDB1 as a critical histone modifier negatively regulating PD‐L1 in ovarian cancer, acting in concert with the TRIM28/KAP1 complex.40 The gene discussed is SETDB1; the disease is ovarian carcinoma.